AAAAAA

   
Results: 1-6 |
Results: 6
Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structures
Authors: Bolin, DR Swain, AL Sarabu, R Berthel, SJ Gillespie, P Huby, NJS Makofske, R Orzechowski, L Perrotta, A Toth, K Cooper, JP Jiang, N Falcioni, F Campbell, R Cox, D Gaizband, D Belunis, CJ Vidovic, D Ito, K Crowther, R Kammlott, U Zhang, XL Palermo, R Weber, D Guenot, J Nagy, Z Olson, GL
Citation: Dr. Bolin et al., Peptide and peptide mimetic inhibitors of antigen presentation by HLA-DR class II MHC molecules. Design, structure-activity relationships, and X-ray crystal structures, J MED CHEM, 43(11), 2000, pp. 2135-2148
The crystal structure of a pyrrolinone-peptide hybrid ligand bound to the human class II MHC protein HLA-DR1
Authors: Lee, KH Olson, GL Bolin, DR Benowitz, AB Sprengeler, PA Smith, AB Hirschmann, RF Wiley, DC
Citation: Kh. Lee et al., The crystal structure of a pyrrolinone-peptide hybrid ligand bound to the human class II MHC protein HLA-DR1, J AM CHEM S, 122(35), 2000, pp. 8370-8375
Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules
Authors: Falcioni, F Ito, K Vidovic, D Belunis, C Campbell, R Berthel, SJ Bolin, DR Gillespie, PB Huby, N Olson, GL Sarabu, R Guenot, J Madison, V Hammer, J Sinigaglia, F Steinmetz, M Nagy, ZA
Citation: F. Falcioni et al., Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules, NAT BIOTECH, 17(6), 1999, pp. 562-567
Synthesis of 1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and evaluation of their affinity for MHC class-II proteins
Authors: Ducry, L Reinelt, S Seiler, P Diederich, F Bolin, DR Campbell, RM Olson, GL
Citation: L. Ducry et al., Synthesis of 1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and evaluation of their affinity for MHC class-II proteins, HELV CHIM A, 82(12), 1999, pp. 2432-2447
Design and synthesis of a competent pyrrolinone-peptide hybrid ligand for the class II major histocompatibility complex protein HLA-DR1
Authors: Smith, AB Benowitz, AB Sprengeler, PA Barbosa, J Guzman, MC Hirschmann, R Schweiger, EJ Bolin, DR Nagy, Z Campbell, RM Cox, DC Olson, GL
Citation: Ab. Smith et al., Design and synthesis of a competent pyrrolinone-peptide hybrid ligand for the class II major histocompatibility complex protein HLA-DR1, J AM CHEM S, 121(40), 1999, pp. 9286-9298
Design, synthesis, and evaluation of a pyrrolinone-peptide hybrid ligand for the class II MHC protein HLA-DR1
Authors: Smith, AB Benowitz, AB Guzman, MC Sprengeler, PA Hirschmann, R Schweiger, EJ Bolin, DR Nagy, Z Campbell, RM Cox, DC Olson, GL
Citation: Ab. Smith et al., Design, synthesis, and evaluation of a pyrrolinone-peptide hybrid ligand for the class II MHC protein HLA-DR1, J AM CHEM S, 120(48), 1998, pp. 12704-12705
Risultati: 1-6 |